CollPlant Biotechnologies (CLGN) Cash from Discontinued Operations (2020 - 2021)
CollPlant Biotechnologies' (CLGN) quarterly Cash from Discontinued Operations came in at 2817000.0 in Q3 2021, down 139.14% YoY from 7197000.0 in Q3 2020, and up 13.59% on a QoQ basis from 3260000.0 in Q2 2021.
CollPlant Biotechnologies (CLGN) Cash from Discontinued Operations (2020 - 2021) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 2 years of Cash from Discontinued Operations data on file, last reported at 2817000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.26 Mn | 4.26 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -2.82 Mn |
| Sep 30, 2021 | -2.82 Mn |
| Jun 30, 2021 | -3.26 Mn |
| Jun 30, 2021 | -3.26 Mn |
| Mar 31, 2021 | 11.00 Mn |
| Mar 31, 2021 | 11.00 Mn |
| Sep 30, 2020 | 7.20 Mn |
| Sep 30, 2020 | 7.20 Mn |
| Jun 30, 2020 | -6.93 Mn |
| Jun 30, 2020 | -6.93 Mn |
| Mar 31, 2020 | 2.59 Mn |
| Mar 31, 2020 | 2.59 Mn |